S Baravelli

Ospedale G.B. Morgagni - L.Pierantoni — Italy

Medicine · Health Sciences

9h-index349citations21works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Platelet Disorders and Treatments(6), Myeloproliferative Neoplasms: Diagnosis and Treatment(4), Immunotherapy and Immune Responses(3), CAR-T cell therapy research(3), Cancer Immunotherapy and Biomarkers(2)

Publications21 total

Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial
Journal of Translational Medicine·2025· 3 citedOpen Access
Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products
Cytotherapy·2024· 3 citedOpen Access
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients
Journal of Translational Medicine·2013· 67 citedOpen Access
Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche(GIMMC).
PubMed·2000· 49 cited
Percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura during pregnancy.
PubMed·1998· 1 cited
Interferon-alpha 2b is not effective in the treatment of refractory immune thrombocytopenic purpura.
PubMed·1998· 11 cited
Effect of PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on growth and differentiation of the HEL cell line.
PubMed·1998· 5 cited
Megakaryocyte progenitors derived from bone marrow or G‐CSF‐mobilized peripheral blood CD34<sup>+</sup> cells show a distinct phenotype and responsiveness to interleukin‐3 (IL‐3) and PEG‐recombinant human megakaryocyte growth and development factor (PEG‐rHuMGDF)
British Journal of Haematology·1998· 8 citedOpen Access
Slimming Diet and the Development of Acute Leukemia: A Possible Relationship? Report of Three Cases
Leukemia & lymphoma/Leukemia and lymphoma·1997
EPIDEMIOLOGICAL, DIAGNOSTIC, THERAPEUTIC AND PROGNOSTIC ASPECTS OF ESSENTIAL THROMBOCYTHEMIA IN RETROSPECTIVE STUDY OF THE GIMMC GROUP IN TWO THOUSAND PATIENTS
1997· 26 cited
Granulocytic Sarcomas: Clinical, Diagnostic and Therapeutical Aspects
Leukemia & lymphoma/Leukemia and lymphoma·1997· 18 cited
Epidermiological, diagnostic, therapeutic and prognostic aspects of essential thrombocithemia in a retrospective study of the GIMMC group in two thousand patients.
Blood·1997· 4 cited
Increased P-selectin plasma levels in patients with thrombotic thrombocytopenic purpura.
PubMed·1996· 11 cited
Acute megakaryoblastic transformation of essential thrombocythemia.
PubMed·1996· 5 cited
Successful treatment of essential thrombocythemia in a pregnancy with recombinant interferon-?2a
The Journal of Maternal-Fetal Medicine·1996· 33 cited
Endothelium and bone marrow transplantation.
PubMed·1996· 45 cited
Negligible hemostatic toxicity of intermediate-dose Erwinase in adult patients with acute lymphoblastic leukemia: preliminary data.
PubMed·1995· 6 cited
Thrombotic thrombocytopenic purpura: relapse and pregnancy.
PubMed·1994· 3 cited
Subconjunctival THC:YAG Laser Sclerostomy for the Treatment of Glaucoma: Preliminary Data
Ophthalmic surgery, lasers & imaging retina·1993· 4 cited
Inflammatory disorders and injuries in children
Current Opinion in Ophthalmology·1992
page 1 of 2Next →

Frequent Co-authors

Nicola Vianelli(12), L Gugliotta(10), S Tura(10), Lucia Catani(7), Laura Ridolfi(3), Massimiliano Petrini(3), Anna Maria Granato(3), Elena Pancisi(3), Francesco De Rosa(3), Emanuela Scarpi(3), Stefano Sacchi(3), Mario Lazzarino(3), Guido Finazzi(3), F Nocentini(3), Valentina Ancarani(2), Massimo Guidoboni(2), Livio Gargantini(2), V. Milano(2), N. Rizzo(2), Roberto Marchioli(2)